A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Resource Type
- Article
- Source
- Targeted Oncology; Nov2023, Vol. 18 Issue 6, p853-868, 16p
- Subject
- Language
- ISSN
- 17762596